Credit Suisse’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $145M | Sell |
1,664,769
-142,649
| -8% | -$12.2M | 0.14% | 134 |
|
|
2023
Q4 | $149M | Sell |
1,807,418
-307,257
| -15% | -$23.4M | 0.14% | 128 |
|
|
2023
Q3 | $166M | Buy |
2,114,675
+14,045
| +0.7% | +$1.18M | 0.17% | 109 |
|
|
2023
Q2 | $185M | Buy |
2,100,630
+38,275
| +2% | +$3.3M | 0.18% | 97 |
|
|
2023
Q1 | $166M | Buy |
2,062,355
+24,667
| +1% | +$2.01M | 0.17% | 112 |
|
|
2022
Q4 | $158M | Buy |
2,037,688
+126,030
| +7% | +$10.2M | 0.17% | 112 |
|
|
2022
Q3 | $154M | Buy |
1,911,658
+22,689
| +1% | +$2.04M | 0.17% | 114 |
|
|
2022
Q2 | $170M | Sell |
1,888,969
-11,728
| -0.6% | -$1.19M | 0.18% | 106 |
|
|
2022
Q1 | $211M | Sell |
1,900,697
-73,648
| -4% | -$7.78M | 0.18% | 101 |
|
|
2021
Q4 | $204M | Sell |
1,974,345
-188,598
| -9% | -$21.8M | 0.11% | 181 |
|
|
2021
Q3 | $271M | Buy |
2,162,943
+11,431
| +0.5% | +$1.48M | 0.15% | 125 |
|
|
2021
Q2 | $268M | Sell |
2,151,512
-443,335
| -17% | -$55.7M | 0.14% | 137 |
|
|
2021
Q1 | $307M | Buy |
2,594,847
+183,307
| +8% | +$21.5M | 0.16% | 114 |
|
|
2020
Q4 | $282M | Sell |
2,411,540
-155,722
| -6% | -$17.1M | 0.14% | 139 |
|
|
2020
Q3 | $267M | Sell |
2,567,262
-271,253
| -10% | -$27.2M | 0.16% | 113 |
|
|
2020
Q2 | $260M | Sell |
2,838,515
-290,060
| -9% | -$27.8M | 0.19% | 101 |
|
|
2020
Q1 | $282M | Buy |
3,128,575
+204,462
| +7% | +$21.8M | 0.24% | 71 |
|
|
2019
Q4 | $332M | Buy |
2,924,113
+490,843
| +20% | +$53.9M | 0.24% | 64 |
|
|
2019
Q3 | $264M | Buy |
2,433,270
+87,828
| +4% | +$9.16M | 0.22% | 72 |
|
|
2019
Q2 | $228M | Buy |
2,345,442
+79,781
| +4% | +$7.28M | 0.2% | 89 |
|
|
2019
Q1 | $206M | Buy |
2,265,661
+48,275
| +2% | +$4.32M | 0.19% | 87 |
|
|
2018
Q4 | $202M | Sell |
2,217,386
-791,526
| -26% | -$74M | 0.21% | 78 |
|
|
2018
Q3 | $296M | Buy |
3,008,912
+525,581
| +21% | +$48.6M | 0.27% | 55 |
|
|
2018
Q2 | $213M | Sell |
2,483,331
-182,672
| -7% | -$15.3M | 0.21% | 80 |
|
|
2018
Q1 | $214M | Sell |
2,666,003
-53,819
| -2% | -$4.44M | 0.2% | 82 |
|
|
2017
Q4 | $220M | Buy |
2,719,822
+210,468
| +8% | +$16.9M | 0.2% | 92 |
|
|
2017
Q3 | $195M | Buy |
2,509,354
+38,585
| +2% | +$3.2M | 0.19% | 90 |
|
|
2017
Q2 | $219M | Sell |
2,470,769
-74,838
| -3% | -$6.31M | 0.21% | 84 |
|
|
2017
Q1 | $205M | Sell |
2,545,607
-66,764
| -3% | -$5.22M | 0.18% | 99 |
|
|
2016
Q4 | $186M | Buy |
2,612,371
+18,214
| +0.7% | +$1.43M | 0.19% | 96 |
|
|
2016
Q3 | $224M | Sell |
2,594,157
-95,366
| -4% | -$8.31M | 0.21% | 84 |
|
|
2016
Q2 | $233M | Buy |
2,689,523
+201,359
| +8% | +$16.3M | 0.26% | 69 |
|
|
2016
Q1 | $187M | Sell |
2,488,164
-353,641
| -12% | -$26.6M | 0.22% | 85 |
|
|
2015
Q4 | $219M | Sell |
2,841,805
-93,491
| -3% | -$7.04M | 0.25% | 76 |
|
|
2015
Q3 | $196M | Sell |
2,935,296
-193,917
| -6% | -$14.3M | 0.24% | 84 |
|
|
2015
Q2 | $232M | Sell |
3,129,213
-287,453
| -8% | -$22M | 0.23% | 89 |
|
|
2015
Q1 | $266M | Buy |
+3,416,666
| New | +$259M | 0.27% | 72 |
|
|
2014
Q4 | – | Sell |
-3,168,841
| Closed | -$196M | – | 4673 |
|
|
2014
Q3 | $196M | Buy |
3,168,841
+889,373
| +39% | +$56.5M | 0.16% | 113 |
|
|
2014
Q2 | $145M | Buy |
2,279,468
+414,468
| +22% | +$25.2M | 0.12% | 161 |
|
|
2014
Q1 | $115M | Sell |
1,865,000
-182,809
| -9% | -$10.6M | 0.11% | 160 |
|
|
2013
Q4 | $118M | Buy |
2,047,809
+210,545
| +11% | +$11.9M | 0.11% | 169 |
|
|
2013
Q3 | $97.8M | Sell |
1,837,264
-455,213
| -20% | -$24.5M | 0.1% | 184 |
|
|
2013
Q2 | $118M | Buy |
+2,292,477
| New | +$113M | 0.12% | 148 |
|
Other funds holding MDT
Credit Suisse's MDT Position: Q1 2024 in Review
Credit Suisse reduced its Medtronic (MDT) stake by 7.9% in Q1 2024, selling an estimated $12.2M and leaving 1,664,769 shares worth $145M. The position accounts for 0.14% of the portfolio, ranked #134.
Credit Suisse first reported a position in MDT in Q2 2013 and has held it in 43 quarters since. The position peaked at $332M in Q4 2019. 2,075 funds tracked by Wall St. Rank hold MDT as of Q1 2024.
- Credit Suisse held 1,664,769 shares of Medtronic worth $145M as of Q1 2024.
- Credit Suisse sold 142,649 Medtronic shares in Q1 2024, an estimated $12.2M.
- Medtronic made up 0.14% of Credit Suisse's portfolio in Q1 2024, its #134 holding.
- Credit Suisse first reported a position in Medtronic in Q2 2013 and has held it in 43 quarters since.
- Credit Suisse's Medtronic position peaked at $332M in Q4 2019.
- 2,075 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.